May 7, 2025
There’s a new kid on the block
Looking at the earnings released by Beta Bionics yesterday it’s safe to say there’s a new kid on the block. After years of languishing under the radar the company under new leadership is showing all the signs of becoming a factor in the insulin pump market. It also shows the further demise of the Medtronic franchise which continues to bleed from every orifice. More evidence will be presented tomorrow afternoon when market leader and king of the castle Insulet reports.
So here are the key questions to answer as we move forward.
- Will Medtronic CEO . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
